SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Nov-22 8:40 AM View: | Roivant Sciences Ltd. (ROIV) | 10-Nov-22 | Private Purchase | 4,000,000 | $5.00 | $20,000,000.00 | 4% 98.85M to 102.85M | |
26-Apr-22 6:48 AM View: | Roivant Sciences Ltd. (ROIV) | 25-Apr-22 | Purchase | 8,600 | $3.91 | $33,635.50 | < 1% 98.84M to 98.85M | |
26-Apr-22 6:48 AM View: | Roivant Sciences Ltd. (ROIV) | 22-Apr-22 | Private Purchase | 31,685 | $3.83 | $121,319.00 | < 1% 98.81M to 98.84M | |
03-Jun-21 5:40 PM View: | Protalix BioTherapeutics, I... (PLX) | 03-Jun-21 | Market Sale | 857,506 | $2.25 | $1,932,300.00 | (19%) 4.49M to 3.64M | (10%) |
03-Jun-21 5:40 PM View: | Protalix BioTherapeutics, I... (PLX) | 02-Jun-21 | Market Sale | 61,211 | $2.56 | $156,553.00 | (1%) 4.56M to 4.49M | 3% |
04-Feb-20 6:41 PM View: | Intec Pharma Ltd. (NTEC) | 04-Feb-20 | Market Sale | 110,000 | $0.29 | $31,900.00 | (3%) 4.34M to 4.23M | 54% |
04-Feb-20 6:41 PM View: | Intec Pharma Ltd. (NTEC) | 03-Feb-20 | Market Sale | 80,000 | $0.32 | $25,440.00 | (2%) 4.42M to 4.34M | 60% |
04-Feb-20 6:41 PM View: | Intec Pharma Ltd. (NTEC) | 31-Jan-20 | Market Sale | 725,951 | $0.31 | $224,319.00 | (14%) 5.15M to 4.42M | 58% |